nodes	percent_of_prediction	percent_of_DWPC	metapath
Proguanil—CYP2E1—Dacarbazine—sarcoma	0.189	0.223	CbGbCtD
Proguanil—CYP2E1—Mitoxantrone—sarcoma	0.147	0.173	CbGbCtD
Proguanil—CYP1A2—Dacarbazine—sarcoma	0.109	0.129	CbGbCtD
Proguanil—CYP3A4—Thiotepa—sarcoma	0.103	0.122	CbGbCtD
Proguanil—CYP2E1—Etoposide—sarcoma	0.0925	0.109	CbGbCtD
Proguanil—CYP1A2—Etoposide—sarcoma	0.0535	0.0632	CbGbCtD
Proguanil—CYP3A4—Mitoxantrone—sarcoma	0.0444	0.0525	CbGbCtD
Proguanil—CYP3A4—Vincristine—sarcoma	0.0306	0.0361	CbGbCtD
Proguanil—CYP2D6—Doxorubicin—sarcoma	0.0301	0.0355	CbGbCtD
Proguanil—CYP3A4—Etoposide—sarcoma	0.028	0.0331	CbGbCtD
Proguanil—Elevated liver enzyme levels—Mitoxantrone—sarcoma	0.0251	0.167	CcSEcCtD
Proguanil—CYP3A4—Doxorubicin—sarcoma	0.0191	0.0226	CbGbCtD
Proguanil—Amylase increased—Thiotepa—sarcoma	0.00704	0.0469	CcSEcCtD
Proguanil—Hepatic enzyme increased—Mitoxantrone—sarcoma	0.00306	0.0204	CcSEcCtD
Proguanil—Pancytopenia—Thiotepa—sarcoma	0.002	0.0133	CcSEcCtD
Proguanil—Pancytopenia—Dactinomycin—sarcoma	0.00198	0.0132	CcSEcCtD
Proguanil—Stomatitis—Thiotepa—sarcoma	0.00183	0.0122	CcSEcCtD
Proguanil—Stomatitis—Dactinomycin—sarcoma	0.00181	0.0121	CcSEcCtD
Proguanil—Hepatobiliary disease—Thiotepa—sarcoma	0.00177	0.0118	CcSEcCtD
Proguanil—Pancytopenia—Vincristine—sarcoma	0.00177	0.0118	CcSEcCtD
Proguanil—Pancytopenia—Mitoxantrone—sarcoma	0.00172	0.0115	CcSEcCtD
Proguanil—Hallucination—Thiotepa—sarcoma	0.00167	0.0111	CcSEcCtD
Proguanil—Stomatitis—Vincristine—sarcoma	0.00162	0.0108	CcSEcCtD
Proguanil—Stomatitis—Mitoxantrone—sarcoma	0.00158	0.0105	CcSEcCtD
Proguanil—Immune system disorder—Thiotepa—sarcoma	0.00152	0.0101	CcSEcCtD
Proguanil—Mediastinal disorder—Thiotepa—sarcoma	0.00152	0.0101	CcSEcCtD
Proguanil—Hallucination—Vincristine—sarcoma	0.00149	0.00989	CcSEcCtD
Proguanil—Mental disorder—Thiotepa—sarcoma	0.00147	0.00982	CcSEcCtD
Proguanil—Erythema—Thiotepa—sarcoma	0.00147	0.00975	CcSEcCtD
Proguanil—Malnutrition—Thiotepa—sarcoma	0.00147	0.00975	CcSEcCtD
Proguanil—Erythema—Dactinomycin—sarcoma	0.00145	0.00968	CcSEcCtD
Proguanil—Pancytopenia—Etoposide—sarcoma	0.00143	0.00955	CcSEcCtD
Proguanil—Mediastinal disorder—Vincristine—sarcoma	0.00135	0.00895	CcSEcCtD
Proguanil—Stomatitis—Etoposide—sarcoma	0.00131	0.00874	CcSEcCtD
Proguanil—Mental disorder—Vincristine—sarcoma	0.00131	0.0087	CcSEcCtD
Proguanil—Cough—Thiotepa—sarcoma	0.00128	0.00851	CcSEcCtD
Proguanil—Hepatobiliary disease—Etoposide—sarcoma	0.00127	0.00848	CcSEcCtD
Proguanil—Erythema—Mitoxantrone—sarcoma	0.00127	0.00842	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00124	0.00825	CcSEcCtD
Proguanil—Nervous system disorder—Thiotepa—sarcoma	0.00117	0.00781	CcSEcCtD
Proguanil—Skin disorder—Thiotepa—sarcoma	0.00116	0.00773	CcSEcCtD
Proguanil—Anorexia—Thiotepa—sarcoma	0.00114	0.00759	CcSEcCtD
Proguanil—Anorexia—Dactinomycin—sarcoma	0.00113	0.00753	CcSEcCtD
Proguanil—Cough—Mitoxantrone—sarcoma	0.0011	0.00735	CcSEcCtD
Proguanil—Immune system disorder—Etoposide—sarcoma	0.00109	0.00727	CcSEcCtD
Proguanil—Mediastinal disorder—Etoposide—sarcoma	0.00109	0.00725	CcSEcCtD
Proguanil—Nervous system disorder—Vincristine—sarcoma	0.00104	0.00692	CcSEcCtD
Proguanil—Decreased appetite—Thiotepa—sarcoma	0.00104	0.00692	CcSEcCtD
Proguanil—Gastrointestinal disorder—Thiotepa—sarcoma	0.00103	0.00687	CcSEcCtD
Proguanil—Decreased appetite—Dactinomycin—sarcoma	0.00103	0.00687	CcSEcCtD
Proguanil—Anorexia—Vincristine—sarcoma	0.00101	0.00673	CcSEcCtD
Proguanil—Skin disorder—Mitoxantrone—sarcoma	0.001	0.00668	CcSEcCtD
Proguanil—Anorexia—Mitoxantrone—sarcoma	0.000984	0.00655	CcSEcCtD
Proguanil—Gastrointestinal pain—Thiotepa—sarcoma	0.000978	0.00651	CcSEcCtD
Proguanil—Gastrointestinal pain—Dactinomycin—sarcoma	0.000971	0.00646	CcSEcCtD
Proguanil—Body temperature increased—Thiotepa—sarcoma	0.000945	0.00629	CcSEcCtD
Proguanil—Abdominal pain—Thiotepa—sarcoma	0.000945	0.00629	CcSEcCtD
Proguanil—Abdominal pain—Dactinomycin—sarcoma	0.000938	0.00625	CcSEcCtD
Proguanil—Body temperature increased—Dactinomycin—sarcoma	0.000938	0.00625	CcSEcCtD
Proguanil—Decreased appetite—Vincristine—sarcoma	0.000922	0.00614	CcSEcCtD
Proguanil—Cough—Etoposide—sarcoma	0.000918	0.00611	CcSEcCtD
Proguanil—Gastrointestinal disorder—Vincristine—sarcoma	0.000916	0.00609	CcSEcCtD
Proguanil—Decreased appetite—Mitoxantrone—sarcoma	0.000898	0.00598	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00089	0.00592	CcSEcCtD
Proguanil—Gastrointestinal pain—Vincristine—sarcoma	0.000867	0.00577	CcSEcCtD
Proguanil—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000844	0.00562	CcSEcCtD
Proguanil—Body temperature increased—Vincristine—sarcoma	0.000838	0.00558	CcSEcCtD
Proguanil—Abdominal pain—Vincristine—sarcoma	0.000838	0.00558	CcSEcCtD
Proguanil—Skin disorder—Etoposide—sarcoma	0.000834	0.00555	CcSEcCtD
Proguanil—Anorexia—Etoposide—sarcoma	0.000819	0.00545	CcSEcCtD
Proguanil—Diarrhoea—Thiotepa—sarcoma	0.000818	0.00545	CcSEcCtD
Proguanil—Abdominal pain—Mitoxantrone—sarcoma	0.000816	0.00543	CcSEcCtD
Proguanil—Body temperature increased—Mitoxantrone—sarcoma	0.000816	0.00543	CcSEcCtD
Proguanil—Diarrhoea—Dactinomycin—sarcoma	0.000812	0.00541	CcSEcCtD
Proguanil—Pancytopenia—Epirubicin—sarcoma	0.000804	0.00535	CcSEcCtD
Proguanil—Vomiting—Thiotepa—sarcoma	0.00076	0.00506	CcSEcCtD
Proguanil—Vomiting—Dactinomycin—sarcoma	0.000755	0.00502	CcSEcCtD
Proguanil—Rash—Thiotepa—sarcoma	0.000754	0.00502	CcSEcCtD
Proguanil—Dermatitis—Thiotepa—sarcoma	0.000753	0.00501	CcSEcCtD
Proguanil—Headache—Thiotepa—sarcoma	0.000749	0.00499	CcSEcCtD
Proguanil—Rash—Dactinomycin—sarcoma	0.000748	0.00498	CcSEcCtD
Proguanil—Decreased appetite—Etoposide—sarcoma	0.000747	0.00497	CcSEcCtD
Proguanil—Pancytopenia—Doxorubicin—sarcoma	0.000744	0.00495	CcSEcCtD
Proguanil—Gastrointestinal disorder—Etoposide—sarcoma	0.000742	0.00494	CcSEcCtD
Proguanil—Stomatitis—Epirubicin—sarcoma	0.000736	0.0049	CcSEcCtD
Proguanil—Diarrhoea—Vincristine—sarcoma	0.000726	0.00483	CcSEcCtD
Proguanil—Hepatobiliary disease—Epirubicin—sarcoma	0.000714	0.00475	CcSEcCtD
Proguanil—Nausea—Thiotepa—sarcoma	0.00071	0.00473	CcSEcCtD
Proguanil—Diarrhoea—Mitoxantrone—sarcoma	0.000707	0.0047	CcSEcCtD
Proguanil—Nausea—Dactinomycin—sarcoma	0.000705	0.00469	CcSEcCtD
Proguanil—Gastrointestinal pain—Etoposide—sarcoma	0.000702	0.00468	CcSEcCtD
Proguanil—Stomatitis—Doxorubicin—sarcoma	0.000681	0.00453	CcSEcCtD
Proguanil—Body temperature increased—Etoposide—sarcoma	0.000679	0.00452	CcSEcCtD
Proguanil—Abdominal pain—Etoposide—sarcoma	0.000679	0.00452	CcSEcCtD
Proguanil—Vomiting—Vincristine—sarcoma	0.000674	0.00449	CcSEcCtD
Proguanil—Rash—Vincristine—sarcoma	0.000669	0.00445	CcSEcCtD
Proguanil—Dermatitis—Vincristine—sarcoma	0.000668	0.00445	CcSEcCtD
Proguanil—Headache—Vincristine—sarcoma	0.000664	0.00442	CcSEcCtD
Proguanil—Hepatobiliary disease—Doxorubicin—sarcoma	0.000661	0.0044	CcSEcCtD
Proguanil—Vomiting—Mitoxantrone—sarcoma	0.000657	0.00437	CcSEcCtD
Proguanil—Rash—Mitoxantrone—sarcoma	0.000651	0.00433	CcSEcCtD
Proguanil—Dermatitis—Mitoxantrone—sarcoma	0.000651	0.00433	CcSEcCtD
Proguanil—Headache—Mitoxantrone—sarcoma	0.000647	0.00431	CcSEcCtD
Proguanil—Nausea—Vincristine—sarcoma	0.00063	0.00419	CcSEcCtD
Proguanil—Nausea—Mitoxantrone—sarcoma	0.000613	0.00408	CcSEcCtD
Proguanil—Immune system disorder—Epirubicin—sarcoma	0.000612	0.00408	CcSEcCtD
Proguanil—Mediastinal disorder—Epirubicin—sarcoma	0.000611	0.00407	CcSEcCtD
Proguanil—Mental disorder—Epirubicin—sarcoma	0.000594	0.00395	CcSEcCtD
Proguanil—Malnutrition—Epirubicin—sarcoma	0.00059	0.00393	CcSEcCtD
Proguanil—Erythema—Epirubicin—sarcoma	0.00059	0.00393	CcSEcCtD
Proguanil—Diarrhoea—Etoposide—sarcoma	0.000588	0.00391	CcSEcCtD
Proguanil—Immune system disorder—Doxorubicin—sarcoma	0.000566	0.00377	CcSEcCtD
Proguanil—Mediastinal disorder—Doxorubicin—sarcoma	0.000565	0.00376	CcSEcCtD
Proguanil—Mental disorder—Doxorubicin—sarcoma	0.000549	0.00366	CcSEcCtD
Proguanil—Vomiting—Etoposide—sarcoma	0.000546	0.00364	CcSEcCtD
Proguanil—Erythema—Doxorubicin—sarcoma	0.000546	0.00363	CcSEcCtD
Proguanil—Malnutrition—Doxorubicin—sarcoma	0.000546	0.00363	CcSEcCtD
Proguanil—Rash—Etoposide—sarcoma	0.000542	0.00361	CcSEcCtD
Proguanil—Dermatitis—Etoposide—sarcoma	0.000541	0.0036	CcSEcCtD
Proguanil—Headache—Etoposide—sarcoma	0.000538	0.00358	CcSEcCtD
Proguanil—Cough—Epirubicin—sarcoma	0.000515	0.00343	CcSEcCtD
Proguanil—Nausea—Etoposide—sarcoma	0.00051	0.0034	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000499	0.00332	CcSEcCtD
Proguanil—Cough—Doxorubicin—sarcoma	0.000476	0.00317	CcSEcCtD
Proguanil—Nervous system disorder—Epirubicin—sarcoma	0.000472	0.00314	CcSEcCtD
Proguanil—Skin disorder—Epirubicin—sarcoma	0.000468	0.00311	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000462	0.00307	CcSEcCtD
Proguanil—Anorexia—Epirubicin—sarcoma	0.000459	0.00306	CcSEcCtD
Proguanil—Nervous system disorder—Doxorubicin—sarcoma	0.000437	0.00291	CcSEcCtD
Proguanil—Skin disorder—Doxorubicin—sarcoma	0.000433	0.00288	CcSEcCtD
Proguanil—Anorexia—Doxorubicin—sarcoma	0.000425	0.00283	CcSEcCtD
Proguanil—Decreased appetite—Epirubicin—sarcoma	0.000419	0.00279	CcSEcCtD
Proguanil—Gastrointestinal disorder—Epirubicin—sarcoma	0.000416	0.00277	CcSEcCtD
Proguanil—Gastrointestinal pain—Epirubicin—sarcoma	0.000394	0.00262	CcSEcCtD
Proguanil—Decreased appetite—Doxorubicin—sarcoma	0.000387	0.00258	CcSEcCtD
Proguanil—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000385	0.00256	CcSEcCtD
Proguanil—Abdominal pain—Epirubicin—sarcoma	0.000381	0.00253	CcSEcCtD
Proguanil—Body temperature increased—Epirubicin—sarcoma	0.000381	0.00253	CcSEcCtD
Proguanil—Gastrointestinal pain—Doxorubicin—sarcoma	0.000364	0.00243	CcSEcCtD
Proguanil—Abdominal pain—Doxorubicin—sarcoma	0.000352	0.00234	CcSEcCtD
Proguanil—Body temperature increased—Doxorubicin—sarcoma	0.000352	0.00234	CcSEcCtD
Proguanil—Diarrhoea—Epirubicin—sarcoma	0.000329	0.00219	CcSEcCtD
Proguanil—Vomiting—Epirubicin—sarcoma	0.000306	0.00204	CcSEcCtD
Proguanil—Diarrhoea—Doxorubicin—sarcoma	0.000305	0.00203	CcSEcCtD
Proguanil—Rash—Epirubicin—sarcoma	0.000304	0.00202	CcSEcCtD
Proguanil—Dermatitis—Epirubicin—sarcoma	0.000303	0.00202	CcSEcCtD
Proguanil—Headache—Epirubicin—sarcoma	0.000302	0.00201	CcSEcCtD
Proguanil—Nausea—Epirubicin—sarcoma	0.000286	0.0019	CcSEcCtD
Proguanil—Vomiting—Doxorubicin—sarcoma	0.000283	0.00189	CcSEcCtD
Proguanil—Rash—Doxorubicin—sarcoma	0.000281	0.00187	CcSEcCtD
Proguanil—Dermatitis—Doxorubicin—sarcoma	0.000281	0.00187	CcSEcCtD
Proguanil—Headache—Doxorubicin—sarcoma	0.000279	0.00186	CcSEcCtD
Proguanil—Nausea—Doxorubicin—sarcoma	0.000265	0.00176	CcSEcCtD
Proguanil—DHFR—myometrium—sarcoma	0.000244	0.0714	CbGeAlD
Proguanil—DHFR—embryo—sarcoma	0.000235	0.0687	CbGeAlD
Proguanil—DHFR—seminal vesicle—sarcoma	0.00022	0.0645	CbGeAlD
Proguanil—DHFR—hematopoietic system—sarcoma	0.00021	0.0613	CbGeAlD
Proguanil—DHFR—connective tissue—sarcoma	0.000202	0.059	CbGeAlD
Proguanil—DHFR—cardiac atrium—sarcoma	0.000159	0.0465	CbGeAlD
Proguanil—DHFR—uterus—sarcoma	0.000158	0.0463	CbGeAlD
Proguanil—CYP2C9—mammary gland—sarcoma	0.000152	0.0444	CbGeAlD
Proguanil—DHFR—lymphoid tissue—sarcoma	0.000148	0.0432	CbGeAlD
Proguanil—DHFR—tendon—sarcoma	0.000139	0.0406	CbGeAlD
Proguanil—DHFR—bone marrow—sarcoma	0.000134	0.0393	CbGeAlD
Proguanil—CYP2C19—hematopoietic system—sarcoma	0.000119	0.0349	CbGeAlD
Proguanil—DHFR—testis—sarcoma	0.000115	0.0336	CbGeAlD
Proguanil—DHFR—liver—sarcoma	0.000109	0.0318	CbGeAlD
Proguanil—CYP1A2—hematopoietic system—sarcoma	9.74e-05	0.0285	CbGeAlD
Proguanil—CYP2C9—hematopoietic system—sarcoma	9.24e-05	0.027	CbGeAlD
Proguanil—CYP2E1—seminal vesicle—sarcoma	9.21e-05	0.027	CbGeAlD
Proguanil—CYP2E1—hematopoietic system—sarcoma	8.76e-05	0.0256	CbGeAlD
Proguanil—DHFR—lymph node—sarcoma	8.32e-05	0.0243	CbGeAlD
Proguanil—CYP3A4—hematopoietic system—sarcoma	7.05e-05	0.0206	CbGeAlD
Proguanil—CYP2D6—hematopoietic system—sarcoma	6.93e-05	0.0203	CbGeAlD
Proguanil—CYP2C19—liver—sarcoma	6.18e-05	0.0181	CbGeAlD
Proguanil—CYP2E1—lymphoid tissue—sarcoma	6.17e-05	0.018	CbGeAlD
Proguanil—CYP2E1—tendon—sarcoma	5.8e-05	0.017	CbGeAlD
Proguanil—CYP1A2—liver—sarcoma	5.04e-05	0.0148	CbGeAlD
Proguanil—CYP2E1—testis—sarcoma	4.8e-05	0.014	CbGeAlD
Proguanil—CYP2C9—liver—sarcoma	4.79e-05	0.014	CbGeAlD
Proguanil—CYP2E1—liver—sarcoma	4.54e-05	0.0133	CbGeAlD
Proguanil—CYP2D6—testis—sarcoma	3.8e-05	0.0111	CbGeAlD
Proguanil—CYP3A4—liver—sarcoma	3.65e-05	0.0107	CbGeAlD
Proguanil—CYP2D6—liver—sarcoma	3.59e-05	0.0105	CbGeAlD
